BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25088194)

  • 1. Autocrine CSF1R signaling mediates switching between invasion and proliferation downstream of TGFβ in claudin-low breast tumor cells.
    Patsialou A; Wang Y; Pignatelli J; Chen X; Entenberg D; Oktay M; Condeelis JS
    Oncogene; 2015 May; 34(21):2721-31. PubMed ID: 25088194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor.
    Patsialou A; Wyckoff J; Wang Y; Goswami S; Stanley ER; Condeelis JS
    Cancer Res; 2009 Dec; 69(24):9498-506. PubMed ID: 19934330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo.
    Zhou ZN; Sharma VP; Beaty BT; Roh-Johnson M; Peterson EA; Van Rooijen N; Kenny PA; Wiley HS; Condeelis JS; Segall JE
    Oncogene; 2014 Jul; 33(29):3784-93. PubMed ID: 24013225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the c-fms proto-oncogene autocrine loop and tumor phenotype in glucocorticoid stimulated human breast carcinoma cells.
    Toy EP; Lamb T; Azodi M; Roy WJ; Woo HH; Chambers SK
    Breast Cancer Res Treat; 2011 Sep; 129(2):411-9. PubMed ID: 21063905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colony-stimulating factor-1 and colony-stimulating factor-1 receptor co-expression is associated with disease progression in gastric cancer.
    Okugawa Y; Toiyama Y; Ichikawa T; Kawamura M; Yasuda H; Fujikawa H; Saigusa S; Ohi M; Araki T; Tanaka K; Inoue Y; Tanaka M; Miki C; Kusunoki M
    Int J Oncol; 2018 Aug; 53(2):737-749. PubMed ID: 29767252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of a pexidartinib bioisostere inhibiting CSF1 production and CSF1R kinase activity in human hepatocellular carcinoma.
    Awasthi BP; Guragain D; Chaudhary P; Jee JG; Kim JA; Jeong BS
    Chem Biol Interact; 2023 Jan; 369():110255. PubMed ID: 36368339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colony-stimulating factor 1 potentiates lung cancer bone metastasis.
    Hung JY; Horn D; Woodruff K; Prihoda T; LeSaux C; Peters J; Tio F; Abboud-Werner SL
    Lab Invest; 2014 Apr; 94(4):371-81. PubMed ID: 24468794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability.
    Murga-Zamalloa C; Rolland DCM; Polk A; Wolfe A; Dewar H; Chowdhury P; Onder O; Dewar R; Brown NA; Bailey NG; Inamdar K; Lim MS; Elenitoba-Johnson KSJ; Wilcox RA
    Clin Cancer Res; 2020 Feb; 26(3):690-703. PubMed ID: 31636099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage-colony stimulating factor (CSF1) predicts breast cancer progression and mortality.
    Richardsen E; Uglehus RD; Johnsen SH; Busund LT
    Anticancer Res; 2015 Feb; 35(2):865-74. PubMed ID: 25667468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells.
    Thakur A; Sun Y; Bollig A; Wu J; Biliran H; Banerjee S; Sarkar FH; Liao DJ
    Clin Cancer Res; 2008 Jul; 14(14):4427-36. PubMed ID: 18628456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion.
    Dai M; Al-Odaini AA; Arakelian A; Rabbani SA; Ali S; Lebrun JJ
    Breast Cancer Res; 2012 Sep; 14(5):R127. PubMed ID: 22995475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of claudin-18 is associated with the proliferative and invasive potential of gastric cancer at the invasive front.
    Oshima T; Shan J; Okugawa T; Chen X; Hori K; Tomita T; Fukui H; Watari J; Miwa H
    PLoS One; 2013; 8(9):e74757. PubMed ID: 24073219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer.
    Wahdan-Alaswad R; Harrell JC; Fan Z; Edgerton SM; Liu B; Thor AD
    Cell Cycle; 2016; 15(8):1046-59. PubMed ID: 26919310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of stable up-regulation of tight junction protein claudin-6 upon biological phenotypes of breast cancer cell MCF-7].
    Wu Q; Liu YF; Ren Y; Xu XM; Yu LN; Li YL; Quan CS
    Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):407-12. PubMed ID: 20367941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF1/CSF1R signaling mediates malignant pleural effusion formation.
    Kosti CN; Vaitsi PC; Pappas AG; Iliopoulou MP; Psarra KK; Magkouta SF; Kalomenidis IT
    JCI Insight; 2022 Mar; 7(6):. PubMed ID: 35315360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma.
    Smeester BA; Slipek NJ; Pomeroy EJ; Laoharawee K; Osum SH; Larsson AT; Williams KB; Stratton N; Yamamoto K; Peterson JJ; Rathe SK; Mills LJ; Hudson WA; Crosby MR; Wang M; Rahrmann EP; Moriarity BS; Largaespada DA
    Bone; 2020 Jul; 136():115353. PubMed ID: 32251854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of glioma-associated oncogene homolog 1 (GLI1) expression in claudin-low breast cancer and crosstalk with the nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) pathway.
    Colavito SA; Zou MR; Yan Q; Nguyen DX; Stern DF
    Breast Cancer Res; 2014 Sep; 16(5):444. PubMed ID: 25252859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tryptophan hydroxylase 1 and 5-HT
    Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
    Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial-like properties of claudin-low breast cancer cells promote tumor vascular permeability and metastasis.
    Harrell JC; Pfefferle AD; Zalles N; Prat A; Fan C; Khramtsov A; Olopade OI; Troester MA; Dudley AC; Perou CM
    Clin Exp Metastasis; 2014 Jan; 31(1):33-45. PubMed ID: 23975155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
    Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.